本文已被:浏览 795次 下载 420次
Received:December 06, 2021 Published Online:July 20, 2022
Received:December 06, 2021 Published Online:July 20, 2022
中文摘要: 目的 评价CT引导下微波消融治疗肺结节的安全性及12例术后患者随访6月的短期治疗效果。
方法 回顾性分析北华大学附属医院胸外科2020年11月至2021年5月接受肺结节微波消融治疗的患者共计12例,记录术后并发症发生情况以及术后1、3、6个月复查胸部CT评估结节病灶局部疗效。
结果 12例患者均成功实施微波消融术,其中术后气胸3例,咯血1例,胸腔积液1例。术后6个月中失访1例,11例患者获得随访。11例患者结节病灶均为完全消融,表现为病灶纤维化、实性结节缩小或局部形成空洞,且术后6个月随访,患者均无再发病灶。
结论 CT引导下经皮微波消融对肺结节治疗的短期临床疗效确切,且并发症少,可作为不能耐受手术或不愿接受手术患者临床治疗肺结节的有效补充手段。
Abstract:Objective To evaluate the safety of CT-guided microwave ablation in the treatment of pulmonary nodules and the short-term curative effects at 6 months after operation. Methods Twelve patients receiving microwave ablation for pulmonary nodules in the Affiliated Hospital of Beihua University from November 2020 to May 2021 were analyzed retrospectively. The postoperative complications were observed, and the local curative effects of pulmonary nodules lesions were evaluated by chest CT at 1-, 3- and 6-month after operation. Results The microwave ablation was successfully performed in all 12 patients. There were 3 cases of postoperative pneumothorax, 1 case of hemoptysis and 1 case of pleural effusion. One patient was lost to follow-up 6 months after operation. The nodular lesions were completely ablated in 11 patients, manifested as focal fibrosis, solid nodule size reduction and local cavity formation. No recurrent lesions were found at 6 months after operation. Conclusion In the treatment of pulmonary nodules, CT-guided percutaneous microwave ablation has definite short-term clinical efficacy with less complications, and can be used as a supplementary means for the patients who cannot tolerate surgery or are unwilling to accept surgery.
文章编号: 中图分类号:R454.9 文献标志码:B
基金项目:吉林省科技发展计划项目(20200403116SF)
Author Name | Affiliation |
LIU Hao*, YANG Yun-long | *Beihua University, Jilin, Jilin 132013, China |
杨云龙1,2 |
Author Name | Affiliation |
LIU Hao*, YANG Yun-long | *Beihua University, Jilin, Jilin 132013, China |
杨云龙1,2 |
引用文本: